A University of Virginia-led team of researchers has made a discovery that may change sepsis treatment for patients in Africa ...
NORFOLK, Va. (WPVI) -- A simple, inexpensive treatment could be the cure for a deadly infection that takes a quarter-million more lives each year - sepsis. Last year, one of those was Oscar-winning ...
Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...
Of all the life-threatening conditions hospitals battle on a daily basis, sepsis is a particularly fickle beast. Despite the difficulties associated with diagnosing this complication, healthcare ...
NORFOLK, Va. -- A critical-care physician at Eastern Virginia Medical School (EVMS) believes he found a simple, inexpensive cure for sepsis. Sepsis is a condition that leads to multiple organ failure.
CytoSorbents highlights the vital and evolving role of CytoSorb® in the treatment of sepsis and septic shock ahead of its World Sepsis Day Global Webinar on September 10th PRINCETON, N.J., July 31, ...
Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms. New research uncovers how different people respond to sepsis based on their genetic makeup, ...
A groundbreaking clinical trial conducted at the Austin Hospital in Melbourne has introduced a new ray of hope for the often-fatal diagnosis of sepsis. Sepsis “is the biggest killer in intensive care ...
USA Health recently became the first and only hospital in the state of Alabama to implement a breakthrough blood test to ...
The immune system is generally a pro at fighting off microbial infections. But sometimes it goes rogue, turning itself on the body’s own organs and tissues, resulting in a life-threating condition ...
A clinical trial led by Steven Opal, professor of medicine at Alpert Medical School, found that the drug Eritoran was no more effective in treating sepsis than a placebo. The study was published in ...